Liquid biopsy study aims to predict pancreatic cancer outcomes
NCT ID NCT04241367
First seen May 01, 2026 · Last updated May 15, 2026 · Updated 4 times
Summary
This study looked at blood samples from 420 people with pancreatic cancer to find genetic markers that could help predict how well treatments work. The goal was to see if a simple blood test (liquid biopsy) could guide doctors in choosing the best therapy. The study did not test a new treatment but focused on gathering information to improve future care.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PANCREAS ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
NATIONAL CANCER CENTER 323, Ilsan-ro, Ilsandong-gu,
Goyang-si, Gyeonggi-do, 410-769, South Korea
Conditions
Explore the condition pages connected to this study.